Based in Sweden, Vicore Pharma is a startup. Brouky records 1 investor associated with the company.
Vicore Pharma is a clinical-stage biopharmaceutical company developing AT2 receptor agonist therapies (notably C21) for the treatment of pulmonary and fibrotic diseases such as idiopathic pulmonary fibrosis and pulmonary arterial hypertension.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.